HIF1A and neoplasm: The levels of HIF-1a subunit are often increased in most solid human tumors including colon, brain, breast, gastric, lung, skin, ovarian, prostate, renal, and pancreatic carcinoma, rendering tumor cells resistant to conventional chemotherapy and selecting a more malignant and invasive phenotype leading to poor prognosis [6].